ClinicalMetric / Countries / Germany / parkinson disease
← 🇩🇪 Germany Trials
🇩🇪 Germany Country × Condition

parkinson disease Clinical Trials in Germany

Active clinical trials for parkinson disease with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 3 // Recruiting: 3 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇩🇪 Germany

Active Trials in Germany (3)

NCT06580977
Recruiting

Exploring the Effects of Exercise on Memory and Cognition in Parkinson´s Disease

Enrollment
60 pts
Country
🇩🇪 Germany
Heidelberg University
View Trial →
NCT07134634
Recruiting

Effect of a Vibrating Therapy Ball on Tremor and Daily Activities in Patients With Different Tremor Syndroms

Enrollment
60 pts
Country
🇩🇪 Germany
Parkinson's Clinic in Beelitz-Heils...
View Trial →
NCT03664609
Recruiting

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Enrollment
5,000 pts
Country
🇩🇪 Germany
Boston Scientific Corporation
View Trial →

Frequently Asked Questions

How many parkinson disease clinical trials are active in Germany?
There are currently 3 active clinical trials for parkinson disease with sites in Germany, of which 3 are actively recruiting patients.
How can I join a parkinson disease clinical trial in Germany?
To join a parkinson disease clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are parkinson disease trials in Germany?
Active parkinson disease trials in Germany span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Germany Trials → Global parkinson disease Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology